Navigation Links
Fat-Fighting Chemical Holds Promise
Date:8/27/2009

But research on 'fatostatin' is still in early stages

THURSDAY, Aug. 27 (HealthDay News) -- Researchers report that a manmade chemical appears to have the power to turn off fat production, potentially turning it into a weapon against obesity.

Fat mice injected with the chemical, known as fatostatin, didn't get fatter and developed lower cholesterol and blood sugar levels, the research team said.

But don't run out and ask your doctor for a fatostatin shot quite yet. While the chemical holds promise as a "starting point" to develop new drugs, it's not a drug itself, said study co-author Motonari Uesugi, a researcher at Kyoto University in Japan.

Still, there's the matter of those mice who didn't put on extra ounces. "When fatostatin is injected, mice did not get fat even when they ate a lot," Uesugi said. Furthermore, "we did not see any obvious side effects or toxic effects," he added.

Researchers have long been trying to find a pill to help people fight obesity. Anti-obesity drugs do exist, but they have side effects that convince some patients to stop using them.

Uesugi said his laboratory has samples of 30,000 chemicals and is testing them on human and mouse cells. The molecule in question, fatostatin, appeared to stop fat production by turning certain genetic switches.

In the new study, published in the Aug. 28 issue of the journal Chemistry and Biology, the researchers report that the chemical prevented obese mice from getting fatter even when they could eat whatever they wanted.

But Uesugi said injection of a drug isn't a good option for people with chronic metabolic diseases, such as those that cause obesity. More research needs to be done to develop a drug that could be taken by mouth and is safe for people, he said.

In regards to safety, fatostatin's "activity on 63 genes, many of which have nothing to do with fat synthesis, raises questions about potential side effects, particularly if the chemical is ingested over many years," noted Dr. Nicholas H.E. Mezitis, assistant professor of clinical medicine at Columbia University College of Physicians and Surgeons, who is familiar with the study findings.

For the moment, it is "still challenging" to develop drugs that safely treat obesity, said metabolism researcher Dr. Tae-Hwa Chun, who also is familiar with the report.

A positive finding "in cells and rodents does not always lead to the development of safe and effective drugs for patients," added Chun, an assistant professor at the University of Michigan who specializes in metabolic syndrome.

Still, Chun said, there's promise in the idea of targeting genetic switches that turn on fat production, as fatostatin appears to do.

More information

Learn more about obesity from the National Institutes of Health.



SOURCES: Motonari Uesugi, Ph.D., researcher, Kyoto University, Japan; Tae-Hwa Chun, M.D., Ph.D., assistant professor, University of Michigan, Ann Arbor; Nicholas H.E. Mezitis, M.D., assistant professor of clinical medicine, Columbia University College of Physicians and Surgeons, New York City; Aug. 28, 2009, Chemistry and Biology


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Chemical culprit in popcorn workers lung identified
2. American Chemical Societys Weekly Presspac -- Sept. 5, 2007
3. Rohm and Haas to Webcast Presentation at Credit Suisse Chemicals Conference
4. Chemical Diversity Initiates International Prostrate Cancer Discovery Partnership
5. Low Doses of Red Wine Chemical May Fight Diabetes
6. National Academies advisory: genes and toxic chemicals
7. Genomic technologies to identify toxic chemicals should be developed
8. Malaria No More and Sumitomo Chemical Help Protect 1.4 Million Kids from Malaria
9. American Chemical Societys Weekly Presspac -- Oct. 17, 2007
10. Researchers study potential health benefits of natural chemicals in muscadine grape seeds
11. Brains Reward Chemical May Help Spur Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Fat-Fighting Chemical Holds Promise
(Date:10/13/2017)... ... October 13, 2017 , ... ... Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate ... primary prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. ...
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... Milford, NJ (PRWEB) , ... October 13, 2017 , ... ... weekend at scenic Alexandria Park in Milford, NJ. This free event, sponsored by ... and physical activity. The fun run is geared towards children of all ages; ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... and Agile Software Development, has been awarded a contract by the Center for ... Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in a ...
(Date:10/12/2017)... ... 2017 , ... First Healthcare Compliance (FHC), an industry leader ... range of technology and learning solutions at the 68th Annual American Healthcare Association ... held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, Nevada. ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)...   Montrium , an industry leader in ... IQPC Trial Master Files & Inspection Readiness Conference ... Clinical Services has selected eTMF Connect ... EastHORN, a leading European contract research organization (CRO), ... to enable greater collaboration with sponsors, improve compliance ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform ... leadership team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led ...
(Date:9/12/2017)... YORK , Sept. 12, 2017   EcoVadis , the leading ... has published the first annual edition of its Global CSR Risk and ... companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 ... ... Index ...
Breaking Medicine Technology: